Baidu
map
FRONT IMMUNOL 润色咨询

Frontiers in Immunology

出版年份:2014 年文章数:22393 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:11.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-07-24 sunyong_97 来自江苏省

    偏重的研究方向:公共数据库;inflammation;生信
    经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article.

    10

    展开10条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2023-05-19 14853348m56暂无昵称 来自上海

    很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-04-11 ms1000001490330585 来自广东省

    Initial Validation 一周了,有一样的同学吗

    13

    展开13条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-08-07 lancet1111 来自广东省

    偏重的研究方向:生信免疫;炎症
    经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-01-22 ms6000000464829773 来自北京

    兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-07-13 嘟嘟啦啦啦 来自辽宁省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:炎症
    经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-05-17 156*****281<手机用户>281 来自天津

    孟德尔还能发吗

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-07-20 ms3000000588233994 来自山西省

    最近卡在Initial Validation多吗?我卡了十天了

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2023-05-27 ms2000000510079560 来自布加勒斯特

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:炎症
    经验分享:效率是真的高,服务是真的好,价格也是真的贵。
    顺便问一句,大家担不担心被中科院预警,我很担心。。。

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2216682, encodeId=a7752216682c3, content=偏重的研究方向:公共数据库;inflammation;生信<br>经验分享:大家看看这是什么意思 Please supply evidence of manuscript construction involving different members of the author group. This can be in the form of: 1. Email messages between the authors that predate initial submission 2. Chat application messages between the authors that predate initial submission and that have been translated to English using the translation function in WeChat 3. Annotated draft(s) of the manuscript If you are a single author, please instead provide all draft versions of your article., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Jul 24 18:50:10 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志!之前审过一篇只有5个figure的文章,无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修,顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改,作者嘴硬的不行,于是我选择了reject。没想到editor把我这个审稿人拒了,这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了,有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218935, encodeId=1ed02218935dd, content=偏重的研究方向:生信免疫;炎症<br>经验分享:无语了,耗时三个月。四个审稿人,反复修回,最后全部审稿人都同意接收了,结果到了FV阶段,总编直接拒稿,真是无语。第一次见这样,真恶心,真是见识到了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Wed Aug 07 15:59:16 CST 2024, time=2024-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183262, encodeId=699e21832625c, content=兄弟们,拒稿原因是Ethical issues or Integrity concerns, or other breach of policy were identified in this manuscript that prevent further review or publication.是什么个情况啊。写的东西都快是全网唯一一个写这破主题的了,每个字都是自己码的,怎么可能会有诚信问题……有没有最近被拒的朋友也是这种情况的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5259154041, createdName=ms6000000464829773, createdTime=Mon Jan 22 19:55:02 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214701, encodeId=7cdf2214e01de, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:炎症<br>经验分享:FII属于F家的王牌期刊了,多年来IF排第一。下面是我的时间线 4月5日投稿 4月8日分配编辑 6月5日收到审稿意见 6月10日开启互动论坛 7月10日接收 编辑很认真,如果遇到英语母语国奖的编辑会很注重语言。然后就是审稿人也很认真,但只要认真回复了,一般会给接收的。回复两个审稿人意见加起来大概35页。仅供参考 祝大家早日accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ed85440623, createdName=嘟嘟啦啦啦, createdTime=Sat Jul 13 07:37:22 CST 2024, time=2024-07-13, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2205264, encodeId=ba28220526494, content=孟德尔还能发吗<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a7a5230025, createdName=156*****281<手机用户>281, createdTime=Fri May 17 17:37:59 CST 2024, time=2024-05-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2215870, encodeId=e0b422158e01f, content=最近卡在Initial Validation多吗?我卡了十天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f778769576, createdName=ms3000000588233994, createdTime=Sat Jul 20 15:26:49 CST 2024, time=2024-07-20, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:炎症<br>经验分享:效率是真的高,服务是真的好,价格也是真的贵。<br>顺便问一句,大家担不担心被中科院预警,我很担心。。。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=2214999, encodeId=72ff221499913, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;免疫治疗<br>经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。<br>第一篇:<br>2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。<br>22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。<br>07 Jul 2023:Review of Reviewer 1 is finalized.<br>08 Aug 2023:Review of Reviewer 2 is finalized.<br>8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。<br>21 Aug 2023:Review of Reviewer 4 is finalized.<br>22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。<br>23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。<br>24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。<br>25 Aug 2023:Review of Review Editor 4 finalized.<br>26 Aug 2023:Review of Review Editor 1 finalized.<br>30 Aug 2023:Review of Review Editor 2 finalized.<br>审稿人3又没回复了。<br>25 Sep 2023:Article accepted for publication.<br>9月26日交费。<br>26 Sep 2023:Typesetting initiated.<br>30 Sep 2023:submitted the author's proof。<br><br><br>第二篇,语言是个大问题啊。<br>2024年1月17日提交《Frontiers in Immunology》<br>2024年03月04日写信催稿<br>3月6日收到回复,说分配编辑了。<br>2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。<br>5月14日写信催稿<br>2024年05月23日收到编辑回复:<br>由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。<br>2024年06月10日Reviewer 3回复,接收<br>2024年6月27日Reviewer 4回复,提了很多问题<br>2024年6月30日提交改稿。<br>2024年6月30日Reviewer 5回复,拒稿。<br>2024年7月10日Reviewer 4建议拒稿,系统退稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0b25252997, createdName=147e6090m64(暂无昵称), createdTime=Mon Jul 15 10:49:31 CST 2024, time=2024-07-15, status=1, ipAttribution=浙江省)]
    2024-07-15 147e6090m64(暂无昵称) 来自浙江省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;免疫治疗
    经验分享:一共投了2次,都是case,第一次很顺利,第二次拒稿了,也和文章质量相关。第一次那个稿件同事改了好多次,还找公司润色了,第二次我是自己写了就投,也慢很多,最后拒稿,哎,下面是时间轴,供大家参考。
    第一篇:
    2023年4月12日提交,然后2023年4月13日被拒了,这么快拒稿,我觉得是系统拒的,应该是格式不符合。于是根据要求,缩减字数和图片。缩减字数太难了,英语太差了,找了语言公司。5月4日给的,二轮修改以及排格式。
    22 May 2023重新提交,2023年06月16日邮件让我推荐审稿人。6月20日回复的编辑社。
    07 Jul 2023:Review of Reviewer 1 is finalized.
    08 Aug 2023:Review of Reviewer 2 is finalized.
    8月几号日看到审稿人3的意见了,是个返修。另外两个都是同意发表的。这个审稿人提的意见挺多的,而且挺细的。15 Aug 2023修改稿件后传回去了。
    21 Aug 2023:Review of Reviewer 4 is finalized.
    22 Aug 2023:Review of Review Editor 3 finalized.这回他是同意发表了。
    23 Aug 2023:因为审稿人4回复了,提了意见,同意发表。此时我是无法提交新的稿件,我就posted new comments。
    24 Aug 2023:Editor reactivated the reviews.我就全部重新评论和重新提交稿件。
    25 Aug 2023:Review of Review Editor 4 finalized.
    26 Aug 2023:Review of Review Editor 1 finalized.
    30 Aug 2023:Review of Review Editor 2 finalized.
    审稿人3又没回复了。
    25 Sep 2023:Article accepted for publication.
    9月26日交费。
    26 Sep 2023:Typesetting initiated.
    30 Sep 2023:submitted the author's proof。


    第二篇,语言是个大问题啊。
    2024年1月17日提交《Frontiers in Immunology》
    2024年03月04日写信催稿
    3月6日收到回复,说分配编辑了。
    2024年03月23日Reviewer 1回复,拒稿,语言太差是一个问题。
    5月14日写信催稿
    2024年05月23日收到编辑回复:
    由于审稿人1建议拒绝,而您的稿件需要2名活跃的审稿人才能在审查过程中继续前进,我们目前正在联系更多的审稿人。我今天亲自发出了几次邀请,我们希望很快收到他们的回复。
    2024年06月10日Reviewer 3回复,接收
    2024年6月27日Reviewer 4回复,提了很多问题
    2024年6月30日提交改稿。
    2024年6月30日Reviewer 5回复,拒稿。
    2024年7月10日Reviewer 4建议拒稿,系统退稿。

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map